Daniel Nisakar Meenakshi Sundaram Email & Phone Number

Edmonton, Ab, Ca

Edmonton, Alberta, Canada

▪ Engage with clients and customers, providing technical details, and functionalities of RJH's technology.▪ Translate technical concepts into scientifically accurate, customer-focused marketing content.▪ Collaborate with the marketing team to design marketing materials for social media platforms.▪ Represent RJH Biosciences at pitch events, conferences, and networking events.▪ Utilize Brevo CRM, LinkedIn ads, and Google ads to achieve marketing objectives. ▪ Develop a Business Innovation Project in collaboration with NRC representatives and the RJH team.

Edmonton, Alberta, Canada

▪ Developed marketing strategies and tactics to improve brand awareness.▪ Conceptualized and created marketing materials showcasing the key value propositions of the products.▪ Utilized LinkedIn advertisement to increase website visibility and tracked campaign performance.▪ Created brochures providing an outlook at RJH Biosciences and their technology. ▪ Established and maintained relationships with the local health ecosystem through participation in events.

Edmonton, Alberta, Canada

▪ Executed multiple oncology-related projects resulting in 17 scientific peer-reviewed publications.▪ Utilized GFP-mRNA, Luciferase-mRNA, and custom mRNA to evaluate the efficacy in mice models.▪ Characterized the size and zeta potential of lipo-polymeric formulations.▪ Evaluated the stability of mRNA/lipo-polymeric formulations at varying temperatures/durations. ▪ Evaluated the intracellular localization of the fluorescent-labeled pDNA and siRNA/lipo-polymers.

Edmonton, Alberta, Canada

▪ Organized and secured a 2-year WCHRI Innovation grant of $60,000 CAD as a Co-Investigator. ▪ Executed a piggyBac transposon-based editing to generate GFP-positive stable cell lines.▪ Implemented PBMC isolation from >25 blood samples in collaboration with the research team. ▪ Planned and organized 3 different screening studies (116, 375, and 446 genes) for target identification. ▪ Trained and supervised students in various cancer gene therapy projects.

Edmonton, Alberta, Canada

▪ Devised stakeholder engagement plans and identified ~100 professionals from academia and industry. ▪ Developed a Business Model Canvas for a therapeutic initiative through the Lab2Market (L2M) program.▪ Engaged in 56 one-on-one scientific exchange meetings to identify the commercialization potential. ▪ Documented the interactions and maintained a detailed customer relationship management file.▪ Communicated the findings to audiences consisting of Biologists, Engineers, CEOs, and Sales experts.

Edmonton, Canada Area

▪ Executed TNF-α, IFN-γ, and IL-6 preclinical safety studies in PBMCs through ELISA and RT-qPCR.▪ Quantitated the extent of target silencing at the mRNA level by RT-qPCR and surface protein levels. ▪ Developed protocols to study cell viability, apoptosis induction, and cell migration.▪ Coordinated with the research team to identify therapeutic gene targets through siRNA library screening.▪ Maintained detailed records of the experimental studies, and executed data analysis using GraphPad.

New Delhi Area, India

▪ Collaborated to develop 3 scientific publications with Dr. Munia Ganguli’s research group.▪ Evaluated the pDNA delivery efficiency and characterization of various Cell Penetrating Peptides.▪ Communicated findings and assisted in the maintenance of lab chemicals, and cell culture consumables.

Chennai, Tamil Nadu, India

▪ Analyzed the type of co-receptor prevalent in HIV-positive patient samples to develop target-specific drugs by culturing U87 glioma cells expressing CCR5/CXCR4 co-receptors.

Doctor Of Philosophy - Phd, Pharmaceutical Sciences

Master Of Science (Msc), Biotechnology

Bachelor Of Science (B.Sc.), Adv. Zoology & Biotechnology

Activities and Societies: NSS